Prevalence of SARS-CoV-2 Antibodies From a National Serosurveillance of Kenyan Blood Donors, January-March 2021.

Uyoga, Sophie; Adetifa, Ifedayo M O; Otiende, Mark; Yegon, Christine; Agweyu, Ambrose; Warimwe, George M; Scott, J Anthony G

Uyoga, Sophie; Adetifa, Ifedayo M O; Otiende, Mark; Yegon, Christine; Agweyu, Ambrose; Warimwe, George M; Scott, J Anthony G.

Uyoga S; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.
Adetifa IMO; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.
Otiende M; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.
Yegon C; Kenya National Blood Transfusion Services, Ministry of Health, Nairobi, Kenya.
Agweyu A; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.
Warimwe GM; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.
Scott JAG; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.

JAMA ; 326(14): 1436-1438, 2021 10 12.

Article in English | MEDLINE | ID: covidwho-1490613

Subject(s)

Antibodies, Viral/blood; Blood Donors; COVID-19/epidemiology; SARS-CoV-2/immunology; Adolescent; Adult; COVID-19/diagnosis; COVID-19 Serological Testing; Female; Humans; Kenya; Male; Middle Aged; Prevalence; Seroepidemiologic Studies; Young Adult

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Blood Donors / SARS-CoV-2 / COVID-19 / Antibodies, Viral Type of study: Diagnostic study / Observational study Limits: Adolescent / Adult / Female / Humans / Male / Middle aged / Young adult Country/Region as subject: Africa Language: English Journal: JAMA Year: 2021 Document Type: Article Affiliation country: Jama.2021.15265

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google